Ratio de rendimiento sobre el capital contable (ROE)
desde 2005
Cálculo
Abiomed Inc., ROE, tendencias a largo plazocálculo
| ROE | = | 100 | × | Utilidad (pérdida) neta1 | ÷ | Capital contable1 | |
|---|---|---|---|---|---|---|---|
| 31 mar 2022 | 9.08% | = | 100 | × | 136,505) | ÷ | 1,503,326) |
| 31 mar 2021 | 16.96% | = | 100 | × | 225,525) | ÷ | 1,329,675) |
| 31 mar 2020 | 19.05% | = | 100 | × | 203,009) | ÷ | 1,065,466) |
| 31 mar 2019 | 27.65% | = | 100 | × | 259,016) | ÷ | 936,890) |
| 31 mar 2018 | 16.27% | = | 100 | × | 112,170) | ÷ | 689,524) |
| 31 mar 2017 | 11.53% | = | 100 | × | 52,116) | ÷ | 452,071) |
| 31 mar 2016 | 10.34% | = | 100 | × | 38,147) | ÷ | 368,775) |
| 31 mar 2015 | 38.99% | = | 100 | × | 113,688) | ÷ | 291,560) |
| 31 mar 2014 | 4.37% | = | 100 | × | 7,351) | ÷ | 168,353) |
| 31 mar 2013 | 10.95% | = | 100 | × | 15,014) | ÷ | 137,080) |
| 31 mar 2012 | 1.18% | = | 100 | × | 1,495) | ÷ | 126,297) |
| 31 mar 2011 | -11.22% | = | 100 | × | (11,755) | ÷ | 104,743) |
| 31 mar 2010 | -17.62% | = | 100 | × | (19,024) | ÷ | 107,956) |
| 31 mar 2009 | -27.24% | = | 100 | × | (31,597) | ÷ | 115,983) |
| 31 mar 2008 | -43.73% | = | 100 | × | (40,930) | ÷ | 93,594) |
| 31 mar 2007 | -22.84% | = | 100 | × | (27,881) | ÷ | 122,095) |
| 31 mar 2006 | -42.38% | = | 100 | × | (29,449) | ÷ | 69,488) |
| 31 mar 2005 | -4.17% | = | 100 | × | (2,342) | ÷ | 56,179) |
Basado en los informes: 10-K (Fecha del informe: 2022-03-31), 10-K (Fecha del informe: 2021-03-31), 10-K (Fecha del informe: 2020-03-31), 10-K (Fecha del informe: 2019-03-31), 10-K (Fecha del informe: 2018-03-31), 10-K (Fecha del informe: 2017-03-31), 10-K (Fecha del informe: 2016-03-31), 10-K (Fecha del informe: 2015-03-31), 10-K (Fecha del informe: 2014-03-31), 10-K (Fecha del informe: 2013-03-31), 10-K (Fecha del informe: 2012-03-31), 10-K (Fecha del informe: 2011-03-31), 10-K (Fecha del informe: 2010-03-31), 10-K (Fecha del informe: 2009-03-31), 10-K (Fecha del informe: 2008-03-31), 10-K (Fecha del informe: 2007-03-31), 10-K (Fecha del informe: 2006-03-31), 10-K (Fecha del informe: 2005-03-31).
1 US$ en miles
Comparación con la competencia
Abiomed Inc., ROE, tendencias a largo plazo, comparación con los competidores
| Abiomed Inc. | Abbott Laboratories | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|---|
| 31 mar 2022 | 9.08% | 18.90% | 5.84% | 16.59% | 11.98% | 9.59% | 25.87% |
| 31 mar 2021 | 16.96% | 19.75% | 10.54% | 16.93% | 14.32% | 7.01% | 24.09% |
| 31 mar 2020 | 19.05% | 13.71% | 10.35% | 13.77% | 10.90% | 9.44% | 23.52% |
| 31 mar 2019 | 27.65% | 11.86% | 10.39% | 15.15% | 16.69% | 9.25% | 24.02% |
| 31 mar 2018 | 16.27% | 7.76% | -1.02% | 13.14% | 16.89% | 6.12% | 23.19% |
| 31 mar 2017 | 11.53% | 1.54% | 17.57% | 14.50% | 13.97% | 8.01% | 22.10% |
| 31 mar 2016 | 10.34% | 6.82% | 14.44% | 9.84% | 12.74% | 6.80% | 18.33% |
| 31 mar 2015 | 38.99% | 20.85% | 14.08% | 11.11% | 13.63% | 5.03% | 17.18% |
| 31 mar 2014 | 4.37% | 10.61% | 12.23% | 10.60% | 12.39% | 15.76% | 17.31% |
| 31 mar 2013 | 10.95% | 10.23% | 12.10% | 10.05% | 19.16% | 18.57% | 17.50% |
| 31 mar 2012 | 1.18% | 22.32% | 10.28% | 11.16% | 18.34% | 21.14% | 17.72% |
| 31 mar 2011 | -11.22% | 19.35% | 9.10% | 11.36% | 18.71% | 19.39% | 18.17% |
| 31 mar 2010 | -17.62% | 20.66% | 9.09% | 12.12% | 18.74% | 21.18% | 17.94% |
| 31 mar 2009 | -27.24% | 25.14% | 10.33% | 19.09% | 15.13% | 16.88% | 16.19% |
| 31 mar 2008 | -43.73% | 27.92% | 9.29% | 11.62% | 16.13% | 19.34% | 14.33% |
| 31 mar 2007 | -22.84% | 20.28% | 8.42% | 14.55% | 16.26% | 25.53% | 23.20% |
| 31 mar 2006 | -42.38% | 12.22% | 13.80% | 12.59% | 12.22% | 27.14% | 19.99% |
| 31 mar 2005 | -4.17% | 23.39% | 14.70% | 9.86% | 21.27% | 17.26% | 18.61% |
Basado en los informes: 10-K (Fecha del informe: 2022-03-31), 10-K (Fecha del informe: 2021-03-31), 10-K (Fecha del informe: 2020-03-31), 10-K (Fecha del informe: 2019-03-31), 10-K (Fecha del informe: 2018-03-31), 10-K (Fecha del informe: 2017-03-31), 10-K (Fecha del informe: 2016-03-31), 10-K (Fecha del informe: 2015-03-31), 10-K (Fecha del informe: 2014-03-31), 10-K (Fecha del informe: 2013-03-31), 10-K (Fecha del informe: 2012-03-31), 10-K (Fecha del informe: 2011-03-31), 10-K (Fecha del informe: 2010-03-31), 10-K (Fecha del informe: 2009-03-31), 10-K (Fecha del informe: 2008-03-31), 10-K (Fecha del informe: 2007-03-31), 10-K (Fecha del informe: 2006-03-31), 10-K (Fecha del informe: 2005-03-31).
Comparativa con el sector industrial: Health Care Equipment & Services
Abiomed Inc., ROE, tendencias a largo plazo, en comparación con el sector industrial: health care equipment & services
| Abiomed Inc. | Health Care Equipment & Services | |
|---|---|---|
| 31 mar 2022 | 9.08% | 15.27% |
| 31 mar 2021 | 16.96% | 15.49% |
| 31 mar 2020 | 19.05% | 14.35% |
| 31 mar 2019 | 27.65% | 14.41% |
| 31 mar 2018 | 16.27% | 9.60% |
| 31 mar 2017 | 11.53% | 13.23% |
| 31 mar 2016 | 10.34% | 11.47% |
| 31 mar 2015 | 38.99% | 12.32% |
| 31 mar 2014 | 4.37% | 13.38% |
| 31 mar 2013 | 10.95% | 13.66% |
| 31 mar 2012 | 1.18% | 15.91% |
| 31 mar 2011 | -11.22% | 14.75% |
| 31 mar 2010 | -17.62% | 15.08% |
| 31 mar 2009 | -27.24% | 16.80% |
| 31 mar 2008 | -43.73% | 14.94% |
| 31 mar 2007 | -22.84% | 16.53% |
| 31 mar 2006 | -42.38% | 16.33% |
| 31 mar 2005 | -4.17% | 16.05% |
Basado en los informes: 10-K (Fecha del informe: 2022-03-31), 10-K (Fecha del informe: 2021-03-31), 10-K (Fecha del informe: 2020-03-31), 10-K (Fecha del informe: 2019-03-31), 10-K (Fecha del informe: 2018-03-31), 10-K (Fecha del informe: 2017-03-31), 10-K (Fecha del informe: 2016-03-31), 10-K (Fecha del informe: 2015-03-31), 10-K (Fecha del informe: 2014-03-31), 10-K (Fecha del informe: 2013-03-31), 10-K (Fecha del informe: 2012-03-31), 10-K (Fecha del informe: 2011-03-31), 10-K (Fecha del informe: 2010-03-31), 10-K (Fecha del informe: 2009-03-31), 10-K (Fecha del informe: 2008-03-31), 10-K (Fecha del informe: 2007-03-31), 10-K (Fecha del informe: 2006-03-31), 10-K (Fecha del informe: 2005-03-31).
Comparación con la industria: Health Care
Abiomed Inc., ROE, tendencias a largo plazo, en comparación con la industria: health care
| Abiomed Inc. | Health Care | |
|---|---|---|
| 31 mar 2022 | 9.08% | 22.94% |
| 31 mar 2021 | 16.96% | 23.78% |
| 31 mar 2020 | 19.05% | 15.95% |
| 31 mar 2019 | 27.65% | 21.79% |
| 31 mar 2018 | 16.27% | 18.65% |
| 31 mar 2017 | 11.53% | 14.05% |
| 31 mar 2016 | 10.34% | 18.22% |
| 31 mar 2015 | 38.99% | 18.18% |
| 31 mar 2014 | 4.37% | 18.58% |
| 31 mar 2013 | 10.95% | 18.25% |
| 31 mar 2012 | 1.18% | 17.51% |
| 31 mar 2011 | -11.22% | 15.27% |
| 31 mar 2010 | -17.62% | 14.32% |
| 31 mar 2009 | -27.24% | 19.27% |
| 31 mar 2008 | -43.73% | 19.00% |
| 31 mar 2007 | -22.84% | 16.88% |
| 31 mar 2006 | -42.38% | 20.24% |
| 31 mar 2005 | -4.17% | 18.16% |
Basado en los informes: 10-K (Fecha del informe: 2022-03-31), 10-K (Fecha del informe: 2021-03-31), 10-K (Fecha del informe: 2020-03-31), 10-K (Fecha del informe: 2019-03-31), 10-K (Fecha del informe: 2018-03-31), 10-K (Fecha del informe: 2017-03-31), 10-K (Fecha del informe: 2016-03-31), 10-K (Fecha del informe: 2015-03-31), 10-K (Fecha del informe: 2014-03-31), 10-K (Fecha del informe: 2013-03-31), 10-K (Fecha del informe: 2012-03-31), 10-K (Fecha del informe: 2011-03-31), 10-K (Fecha del informe: 2010-03-31), 10-K (Fecha del informe: 2009-03-31), 10-K (Fecha del informe: 2008-03-31), 10-K (Fecha del informe: 2007-03-31), 10-K (Fecha del informe: 2006-03-31), 10-K (Fecha del informe: 2005-03-31).